The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad
Since elevated serum levels of trimethylamine N-oxide (TMAO) were first associated with increased risk of cardiovascular disease (CVD), TMAO research among chronic diseases has grown exponentially. We now know that serum TMAO accumulation begins with dietary choline metabolism across the microbiome-...
Main Authors: | Emily S. Krueger, Trevor S. Lloyd, Jeffery S. Tessem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/8/2873 |
Similar Items
-
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies
by: Edoardo Tacconi, et al.
Published: (2023-01-01) -
Gut microbiota dependant trimethylamine N-oxide and hypertension
by: Katongo H. Mutengo, et al.
Published: (2023-04-01) -
Association of the Chronotype Score with Circulating Trimethylamine N-Oxide (TMAO) Concentrations
by: Luigi Barrea, et al.
Published: (2021-05-01) -
The gut microbe-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus
by: Salah Mohamed, et al.
Published: (2024-01-01) -
Diet, Fecal Microbiome, and Trimethylamine N-Oxide in a Cohort of Metabolically Healthy United States Adults
by: Kristen L. James, et al.
Published: (2022-03-01)